$33.58
0.24% today
Nasdaq, Dec 30, 09:19 pm CET
ISIN
US4158581094
Symbol
HROW
Sector
Industry

Harrow Health, Inc. Target price 2024 - Analyst rating & recommendation

Harrow Health, Inc. Classifications & Recommendation:

Buy
100%

Harrow Health, Inc. Price Target

Target Price $59.85
Price $33.50
Potential
Number of Estimates 4
4 Analysts have issued a price target Harrow Health, Inc. 2025 . The average Harrow Health, Inc. target price is $59.85. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 4 Analysts recommend Harrow Health, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Harrow Health, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Harrow Health, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 130.19 191.85
46.94% 47.36%
EBITDA Margin 9.92% 17.12%
60.45% 72.51%
Net Margin -20.51% -12.20%
0.08% 40.53%

4 Analysts have issued a sales forecast Harrow Health, Inc. 2024 . The average Harrow Health, Inc. sales estimate is

$192m
Unlock
. This is
13.43% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$193m 13.96%
Unlock
, the lowest is
$191m 13.02%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $130m 46.94%
2024
$192m 47.36%
Unlock
2025
$283m 47.76%
Unlock
2026
$427m 50.80%
Unlock
2027
$705m 64.84%
Unlock

4 Analysts have issued an Harrow Health, Inc. EBITDA forecast 2024. The average Harrow Health, Inc. EBITDA estimate is

$32.8m
Unlock
. This is
712.89% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$34.5m 755.02%
Unlock
, the lowest is
$31.9m 690.10%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $12.9m 135.77%
2024
$32.8m 154.19%
Unlock
2025
$79.6m 142.33%
Unlock
2026
$156m 96.46%
Unlock
2027
$309m 97.78%
Unlock

EBITDA Margin

2023 9.92% 60.45%
2024
17.12% 72.51%
Unlock
2025
28.07% 63.96%
Unlock
2026
36.58% 30.32%
Unlock
2027
43.89% 19.98%
Unlock

4 Harrow Health, Inc. Analysts have issued a net profit forecast 2024. The average Harrow Health, Inc. net profit estimate is

$-23.4m
Unlock
. This is
30.06% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-22.1m 34.04%
Unlock
, the lowest is
$-24.6m 26.60%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-26.7m 47.06%
2024
$-23.4m 12.35%
Unlock
2025
$20.1m 185.95%
Unlock
2026
$81.6m 305.32%
Unlock
2027
$188m 130.56%
Unlock

Net Margin

2023 -20.51% 0.08%
2024
-12.20% 40.53%
Unlock
2025
7.10% 158.20%
Unlock
2026
19.08% 168.73%
Unlock
2027
26.68% 39.83%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.75 -0.66
47.06% 12.00%
P/E negative
EV/Sales 6.86

4 Analysts have issued a Harrow Health, Inc. forecast for earnings per share. The average Harrow Health, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.66
Unlock
. This is
29.79% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.62 34.04%
Unlock
, the lowest is
$-0.69 26.60%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.75 47.06%
2024
$-0.66 12.00%
Unlock
2025
$0.57 186.36%
Unlock
2026
$2.29 301.75%
Unlock
2027
$5.28 130.57%
Unlock

P/E ratio

Current -35.60 51.75%
2024
-50.95 43.12%
Unlock
2025
59.29 216.37%
Unlock
2026
14.63 75.32%
Unlock
2027
6.34 56.66%
Unlock

Based on analysts' sales estimates for 2024, the Harrow Health, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.78 82.63%
2024
6.86 11.82%
Unlock
2025
4.64 32.32%
Unlock
2026
3.08 33.69%
Unlock
2027
1.87 39.34%
Unlock

P/S ratio

Current 7.05 116.96%
2024
6.22 11.84%
Unlock
2025
4.21 32.32%
Unlock
2026
2.79 33.69%
Unlock
2027
1.69 39.34%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today